INBX Stock Price
Inhibrx Biosciences, Inc.
INBX stock price is $85.26 (-2.09% on the day), giving Inhibrx Biosciences, Inc. a market cap of $1.25B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
INBX Stock Overview
- Price
- $85.26
- Previous close
- $87.08
- Open
- $86.23
- Market cap
- $1.25B
- P/E ratio
- -9.0
- 52-week range
- $46.01 - $155.29
- 1-year price target
- $266.67
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NGS
- MarketXLS Rank
- 38
About Inhibrx Biosciences, Inc.
Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates includes INBRX-109, a tetravalent therapeutic candidate targeting death-receptor 5 that is in phase 2 clinical trial for the treatment of unresectable or metastatic conventional chondrosarcoma; and INBRX-106, a hexavalent sdAb-based therapeutic candidate targeting OX4 that is in phase 2 clinical trial for the treatment of metastatic solid tumor, non-small cell lung cancer, melanoma, head and neck cancer, gastric (GIST) and gastroesophageal adenocarcinoma (GEA) cancer, renal cell carcinoma, and urothelial (transitional) cell carcinoma. Inhibrx Biosciences, Inc. was incorporated in 2024 and is based in La Jolla, California.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | INBX | $85.26 | -2.1% | 246.06K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Inhibrx Biosciences, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW